Skip to main content
Log in

Serum aluminum levels in alzheimer’s disease and other senile dementias

  • Part VII Neurology and Aging
  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

The exact cause of Alzheimer’s disease and the part played in it by aluminum is still speculative. We have studied serum aluminum in 356 healthy people, and we have observed that serum aluminum concentration is increased in aging people in relation to age. We suggest that this could be associated with an enhanced gastric permeability or by an increase in metal accumulation proportional to age. We have measured serum aluminum levels in patients with probable Alzheimer’s disease, patients with other senile dementias, and agematched group. Patients with probable Alzheimer’s disease have statistically significant higher serum aluminum levels than patients with other types of senile dementias (alcoholic, vascular, multi-infart) and an age-matched control group. When we compare serum aluminum of patients with senile dementias from other causes with the agematched control group, we do not find significant differences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E. J. Underwood,Trace Elements in Human and Animal Nutrition, 3rd ed. Academic New York (1971).

    Google Scholar 

  2. G. A. Trapp,Neurotoxicol. 1, 89–100 (1980).

    CAS  Google Scholar 

  3. D. P. Perl, and A. R. Brody,Science 208, 297–299 (1980).

    Article  PubMed  CAS  Google Scholar 

  4. J. M. Candy, J. Klinowski, R. H. Perry, A. Fairbairm, A. E. Oakley, and J. A. Edwardson,Lancet 1, 354–357 (1986).

    Article  PubMed  CAS  Google Scholar 

  5. T. VogtWater Quality and Health Study of a Possible Relationship Between Aluminum in Drinking Water and Dementia (Sosiale og okonomiske studier 61; English abstract) Central Bureau of Statistics of Norway, Oslo (1986).

    Google Scholar 

  6. C. N. Martyn, D. J. P. Barker, C. Osmond, E. C. Harris, J. A. Edwardson, and R. F. Lacey,Lancet 1, 59–62 (1989).

    PubMed  CAS  Google Scholar 

  7. G. McKhann, D. Drackman, and M. Folstein,Neurology 34, 939 (1984).

    PubMed  CAS  Google Scholar 

  8. D. Shore, S. W. King, W. Kaye, E. F. Tousey, H. J. Winfrey, S. G. Potkin, D. R. Weinberg, J. Sovovy, M. R. Wills, and R. S. Wyatt,Neurotoxicology 1, 55–63 (1980).

    CAS  Google Scholar 

  9. J. M. Kellet, A. Taylor, and J. J. Oram,Lancet 1, 682 (1986).

    Google Scholar 

  10. G. J. Naylor, A. H. W. Smith, A. McHarg, P. J. Walker, B. Shepherd, N. J. Ward, and M. Harper,Trace Element Med. 6, 93–95 (1989).

    Google Scholar 

  11. J. L. Fernandez Martin, M. Macho, E. Gomez Granda, B. Diaz Lopez, A. Sanz Medel, and J. B. Cannata,Rev. Clin. Exp. 185, 14–18 (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zapatero, M.D., Garcia de Jalon, A., Pascual, F. et al. Serum aluminum levels in alzheimer’s disease and other senile dementias. Biol Trace Elem Res 47, 235–240 (1995). https://doi.org/10.1007/BF02790122

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02790122

Index Entries

Navigation